Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key.
Nathan den BroederChantal A M BoumanWietske KievitNoortje van HerwaardenFrank H J van den HoogenRonald F van VollenhovenHans W J BijlsmaAatke van der MaasAlfons A den BroederPublished in: Annals of the rheumatic diseases (2018)
Keyphrases